Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals

Miranda Surjadi1

  • 11 University of California, San Francisco.

Workplace Health & Safety
|January 24, 2018
PubMed

Insights

Hepatitis C virus (HCV) screening is recommended for all adults, presenting an opportunity for workplace outreach. Occupational health nurses can facilitate HCV testing and linkage to care, leveraging new curative treatments.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a significant global health concern, affecting millions in the US, with many undiagnosed.
  • Workplace screening for bloodborne pathogens (BBP) typically occurs post-exposure, but broader HCV screening is less understood.
  • New CDC guidelines recommend universal HCV screening for individuals born between 1945-1965, irrespective of risk factors.

Purpose of the Study:

  • To review Hepatitis C virus (HCV) management in the era of direct-acting antivirals (DAAs).
  • To highlight the opportunity for workplace-based HCV outreach and screening.
  • To emphasize the role of occupational health nurses in HCV identification and care linkage.

Main Methods:

  • Review of current HCV epidemiology and diagnostic guidelines.
  • Analysis of the impact of direct-acting antiviral (DAA) therapies on HCV treatment.
  • Discussion of workplace strategies for HCV education, screening, and referral.

Main Results:

  • Direct-acting antivirals (DAAs) offer a cure for Hepatitis C virus (HCV).
  • Universal HCV screening recommendations create a new avenue for early detection.
  • Worksite interventions can increase HCV awareness and testing.

Conclusions:

  • Occupational health nurses are pivotal in identifying potential HCV-positive individuals within the workplace.
  • Worksite screening and education programs can improve HCV diagnosis rates.
  • Linking identified individuals to specialists ensures access to curative DAA treatment, reducing the HCV burden.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.8K
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
2.9K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.2K
Evaluating Limits by Direct Substitution01:29

Evaluating Limits by Direct Substitution

In the analysis of functions that represent continuous physical phenomena, it is often necessary to determine the output value as the input approaches a specific point. When a combination of algebraic terms defines the function and exhibits no discontinuities or abrupt changes near the point of interest, the limit of the function can be evaluated directly. This process, known as direct substitution, involves replacing the variable in the expression with the value it approaches.Direct...
191